33 Pageviews Read Stories
Causes: Health, Medical Disciplines Research
Mission: The organization is doing research to uncover the molecular basis of cancer and degenerative diseases with the emphasis on multiple myeloma.
Programs: In may 2008 the organization started a collaboration with scientists at wake forest university who have developed a protocol for using granulocytes for treating solid tumors. The protocol was modified for implementation and investigational new drug approval was obtained in october 2008 for a phase i/ii clinical trial for 29 patients. Western institutional review board approval was obtained in novemeber 2008. Through 2016, 12 patients have been evaluated, 12 patients have been treated and 215 donors have been evaluated.